Total Payments
$134,946
2024 Payments
$22,272
Companies
9
Transactions
147
Medicare Patients
1,308
Medicare Billing
$642,658
Payment Breakdown by Category
Consulting$54,707 (40.5%)
Other$50,433 (37.4%)
Travel$24,888 (18.4%)
Food & Beverage$4,918 (3.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $54,707 | 21 | 40.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $43,433 | 13 | 32.2% |
| Travel and Lodging | $24,888 | 53 | 18.4% |
| Honoraria | $7,000 | 3 | 5.2% |
| Food and Beverage | $4,918 | 57 | 3.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Veloxis Pharmaceuticals, Inc. | $69,822 | 87 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $42,997 | 23 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $20,754 | 21 | $0 (2023) |
| Organ Recovery Systems, Inc. | $604.31 | 4 | $0 (2024) |
| XVIVO Perfusion Inc. | $407.41 | 4 | $0 (2023) |
| GlaxoSmithKline, LLC. | $123.95 | 1 | $0 (2018) |
| GENZYME CORPORATION | $117.49 | 1 | $0 (2022) |
| AbbVie Inc. | $104.23 | 5 | $0 (2020) |
| Relypsa, Inc. | $14.93 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $22,272 | 11 | SANOFI-AVENTIS U.S. LLC ($21,696) |
| 2023 | $36,209 | 42 | SANOFI-AVENTIS U.S. LLC ($21,301) |
| 2022 | $33,984 | 32 | Veloxis Pharmaceuticals, Inc. ($33,867) |
| 2021 | $5,397 | 6 | Veloxis Pharmaceuticals, Inc. ($5,397) |
| 2020 | $17,062 | 22 | Veloxis Pharmaceuticals, Inc. ($8,785) |
| 2019 | $15,958 | 19 | Veloxis Pharmaceuticals, Inc. ($9,731) |
| 2018 | $4,048 | 14 | Veloxis Pharmaceuticals, Inc. ($3,838) |
| 2017 | $14.93 | 1 | Relypsa, Inc. ($14.93) |
All Payment Transactions
147 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | SANOFI-AVENTIS U.S. LLC | THYMOGLOBULIN (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,063.00 | General |
| Category: Oncology | ||||||
| 09/13/2024 | SANOFI-AVENTIS U.S. LLC | THYMOGLOBULIN (Biological) | Consulting Fee | Cash or cash equivalent | $4,690.00 | General |
| Category: Oncology | ||||||
| 09/04/2024 | Organ Recovery Systems, Inc. | — | Food and Beverage | In-kind items and services | $205.73 | General |
| 09/04/2024 | Organ Recovery Systems, Inc. | — | Food and Beverage | In-kind items and services | $71.55 | General |
| 08/21/2024 | SANOFI-AVENTIS U.S. LLC | THYMOGLOBULIN (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,313.00 | General |
| Category: Oncology | ||||||
| 06/04/2024 | SANOFI-AVENTIS U.S. LLC | THYMOGLOBULIN (Biological) | Food and Beverage | In-kind items and services | $142.38 | General |
| Category: Oncology | ||||||
| 06/02/2024 | SANOFI-AVENTIS U.S. LLC | THYMOGLOBULIN (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $9,188.00 | General |
| Category: Oncology | ||||||
| 06/02/2024 | SANOFI-AVENTIS U.S. LLC | THYMOGLOBULIN (Biological) | Food and Beverage | In-kind items and services | $94.68 | General |
| Category: Oncology | ||||||
| 03/22/2024 | SANOFI-AVENTIS U.S. LLC | THYMOGLOBULIN (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,063.00 | General |
| Category: Oncology | ||||||
| 01/12/2024 | SANOFI-AVENTIS U.S. LLC | THYMOGLOBULIN (Biological) | Food and Beverage | In-kind items and services | $142.37 | General |
| Category: Oncology | ||||||
| 01/11/2024 | Organ Recovery Systems, Inc. | — | Food and Beverage | In-kind items and services | $298.09 | General |
| 12/11/2023 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $5,062.50 | General |
| 12/08/2023 | E.R. Squibb & Sons, L.L.C. | — | Travel and Lodging | Cash or cash equivalent | $203.51 | General |
| 12/08/2023 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $11.30 | General |
| 12/02/2023 | E.R. Squibb & Sons, L.L.C. | — | Travel and Lodging | Cash or cash equivalent | $451.97 | General |
| 12/02/2023 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $135.00 | General |
| 12/02/2023 | E.R. Squibb & Sons, L.L.C. | — | Travel and Lodging | Cash or cash equivalent | $76.37 | General |
| 12/02/2023 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $61.91 | General |
| 12/02/2023 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $50.00 | General |
| 12/02/2023 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $28.55 | General |
| 12/02/2023 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $25.70 | General |
| 12/01/2023 | E.R. Squibb & Sons, L.L.C. | — | Travel and Lodging | Cash or cash equivalent | $160.17 | General |
| 11/08/2023 | SANOFI-AVENTIS U.S. LLC | THYMOGLOBULIN (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,132.00 | General |
| Category: Oncology | ||||||
| 08/15/2023 | SANOFI-AVENTIS U.S. LLC | THYMOGLOBULIN (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,481.00 | General |
| Category: Oncology | ||||||
| 08/15/2023 | SANOFI-AVENTIS U.S. LLC | THYMOGLOBULIN (Biological) | Travel and Lodging | In-kind items and services | $1,323.28 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 376 | 412 | $723,509 | $171,062 |
| 2022 | 11 | 326 | 409 | $694,236 | $171,905 |
| 2021 | 11 | 317 | 463 | $551,165 | $144,944 |
| 2020 | 7 | 289 | 441 | $611,735 | $154,748 |
Total Patients
1,308
Total Services
1,725
Medicare Billing
$642,658
Procedure Codes
40
All Medicare Procedures & Services
40 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 50360 | Transplantation of donor kidney | Facility | 2023 | 57 | 57 | $436,140 | $114,492 | 26.3% |
| 37799 | Other procedure on blood vessel | Facility | 2023 | 20 | 20 | $59,200 | $12,841 | 21.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 53 | 66 | $40,060 | $10,253 | 25.6% |
| 50323 | Preparation of donor kidney for transplantation | Facility | 2023 | 48 | 48 | $59,736 | $8,080 | 13.5% |
| 37607 | Tying or banding of surgically created artery-vein connection | Facility | 2023 | 27 | 27 | $33,400 | $7,455 | 22.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 49 | 57 | $24,760 | $6,483 | 26.2% |
| 50329 | Preparation of donor kidney and ureter for transplantation | Facility | 2023 | 54 | 54 | $30,104 | $3,936 | 13.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 13 | 27 | $9,265 | $2,799 | 30.2% |
| 50327 | Preparation of donor kidney and veins for transplantation | Facility | 2023 | 27 | 27 | $18,109 | $2,366 | 13.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 16 | 17 | $5,255 | $1,377 | 26.2% |
| 50328 | Preparation of donor kidney and arteries for transplantation | Facility | 2023 | 12 | 12 | $7,480 | $979.92 | 13.1% |
| 50360 | Transplantation of donor kidney | Facility | 2022 | 59 | 59 | $474,386 | $124,669 | 26.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 62 | 93 | $56,520 | $15,085 | 26.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 37 | 75 | $25,125 | $6,602 | 26.3% |
| 50323 | Preparation of donor kidney for transplantation | Facility | 2022 | 36 | 36 | $47,160 | $6,121 | 13.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 40 | 49 | $21,235 | $5,599 | 26.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 24 | 24 | $15,600 | $3,995 | 25.6% |
| 37607 | Tying or banding of surgically created artery-vein connection | Facility | 2022 | 12 | 12 | $14,880 | $3,951 | 26.6% |
| 50325 | Preparation of living donor kidney for transplantation | Facility | 2022 | 20 | 20 | $17,900 | $2,397 | 13.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 12 | 17 | $5,260 | $1,323 | 25.1% |
| 50327 | Preparation of donor kidney and veins for transplantation | Facility | 2022 | 13 | 13 | $9,295 | $1,240 | 13.3% |
| 50328 | Preparation of donor kidney and arteries for transplantation | Facility | 2022 | 11 | 11 | $6,875 | $921.12 | 13.4% |
| 50360 | Transplantation of donor kidney | Facility | 2021 | 40 | 40 | $324,200 | $87,578 | 27.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 56 | 105 | $51,450 | $17,298 | 33.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 40 | 117 | $40,365 | $10,505 | 26.0% |
About Dr. Michael Goldstein, MD
Dr. Michael Goldstein, MD is a Transplant Surgery healthcare provider based in Hackensack, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1962426601.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Goldstein, MD has received a total of $134,946 in payments from pharmaceutical and medical device companies, with $22,272 received in 2024. These payments were reported across 147 transactions from 9 companies. The most common payment nature is "Consulting Fee" ($54,707).
As a Medicare-enrolled provider, Goldstein has provided services to 1,308 Medicare beneficiaries, totaling 1,725 services with total Medicare billing of $642,658. Data is available for 4 years (2020–2023), covering 40 distinct procedure/service records.
Ad
Practice Information
- Specialty Transplant Surgery
- Other Specialties Transplant Surgery, Surgery
- Location Hackensack, NJ
- Active Since 07/26/2006
- Last Updated 05/11/2017
- Taxonomy Code 204F00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1962426601
Products in Payments
- Envarsus (Drug) $57,779
- THYMOGLOBULIN (Biological) $43,114
- NULOJIX (Biological) $14,487
- ENVARSUS (Drug) $8,205
- Envarsus XR (SP) (Drug) $3,838
- SHINGRIX (Biological) $123.95
- Humira (Biological) $66.53
- CREON (Drug) $17.86
- Veltassa (Drug) $14.93
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.